HPC-Therapy

Extensive studies of the scientific literature and years of experience with laser therapy, cryotherapy and thermotherapy enabled our researchers to develop HPC therapy, the “high performance combination”, which achieves particularly good anti-inflammatory effects.

Our research focused on further improving the scientifically known anti-inflammatory effects of laser and cryotherapy. Laser technology can already achieve a good anti-inflammatory effect, but inflamed tissue has an excessive concentration of water molecules in the acute phase, which reduces or even eliminates the therapeutic effect of the laser. Inflamed tissue in the chronic phase requires an increase in microcirculation instead.

HPC therapy consists of a combination of laser therapy, cryotherapy and thermotherapy.

In the case of acute inflammation, we recommend starting contrast therapy® with the “anti-inflammatory” – “acute phase” program (cycles of heat and cold, ending with cold), followed by laser treatment (select “effect – anti-inflammatory”) and finally cryotherapy. By ending the cold application, the excellent anti-inflammatory and analgesic effect of cryotherapy is used and the tissue heated by the laser treatment is cooled down again.

In the case of chronic inflammation, however, the tissue should not be cooled but heated. To avoid vasodilation of the vessels by contrast therapy® before applying laser therapy, we recommend starting laser treatment directly (select “effect – anti-inflammatory”) and then finishing with contrast therapy®, program: “anti-inflammatory – chronic phase” (cycles of heat and cold, ending with heat).

It is the combination of the effects of these different therapies that enables a much more efficient improvement of the clinical picture after just a few treatments.